{"schema_version":"1","generated_at":"2026-10-31T09:48:48.658Z","data_as_of":"2026-10-30","url":"https://www.findmykol.com/kol/katherine-twombley","json_url":"https://www.findmykol.com/kol/katherine-twombley/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"katherine-twombley","name":"Katherine Twombley","credential":"MD","title":"Chair, Department of Pediatrics","specialty":"Pediatric Nephrology","specialty_raw":"Pediatric Nephrology","therapeutic_area":"Genitourinary","therapeutic_areas":["Genitourinary"],"institution":"Mayo Clinic Florida","institution_url":"https://www.findmykol.com/institution/mayo-clinic","city":"Jacksonville","state":"FL","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1356532311","orcid":"0000-0003-2073-2834","openalex":"A5035513932"},"summary":"Katherine Twombley is Chair, Department of Pediatrics at Mayo Clinic Florida. OpenAlex indexes 118 publications with 2,246 citations (h-index 24); ClinicalTrials.gov lists 1 registered study with this person as an investigator.","overview":{"text":"Katherine Twombley, M.D., is Chair, Department of Pediatrics at Mayo Clinic Florida. The public record shows 118 publications with 2,246 citations (h-index 24), centered on Renal Diseases and Glomerulopathies, Renal Transplantation Outcomes and Treatments, Chronic Kidney Disease and Diabetes. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 6 companies.","bullets":["Most recent indexed publication: 2026 · Pediatric transplantation","Top research focus: Renal Diseases and Glomerulopathies","1 registered trials on ClinicalTrials.gov","Open Payments reporting from 6 companies"],"generated_at":"2026-10-30"},"focus":{"indications":[{"label":"Chronic Kidney Disease","therapeutic_area":"Nephrology","trials":1,"topics":1,"strength":4},{"label":"Renal Insufficiency, Chronic","therapeutic_area":"Nephrology","trials":1,"topics":0,"strength":3},{"label":"Renal Insufficiency","therapeutic_area":"Nephrology","trials":1,"topics":0,"strength":3},{"label":"Liver Failure","therapeutic_area":"Gastroenterology","trials":1,"topics":0,"strength":3},{"label":"Liver Failure, Acute","therapeutic_area":"Gastroenterology","trials":1,"topics":0,"strength":3}],"research_topics":["Renal Diseases and Glomerulopathies","Renal Transplantation Outcomes and Treatments","Chronic Kidney Disease and Diabetes","Transplantation: Methods and Outcomes","Organ Donation and Transplantation"],"drugs_studied":{"total":5,"shown":3,"withheld":2,"rows":[{"name":"PROCYSBI","trials":0,"payments":21,"publications":0,"mentions":21},{"name":"Ultomiris","generic":"Ravulizumab","trials":0,"payments":21,"publications":0,"mentions":21},{"name":"Filspari","generic":"Sparsentan","trials":0,"payments":7,"publications":0,"mentions":7}]},"works_with":{"total":7,"shown":3,"withheld":4,"rows":[{"name":"Alexion Pharmaceuticals, Inc.","trials":0,"payments":30,"mentions":30},{"name":"Horizon Therapeutics plc","trials":0,"payments":21,"mentions":21},{"name":"Travere Therapeutics, Inc.","trials":0,"payments":8,"mentions":8}]}},"scholarship":{"works_count":118,"cited_by_count":2246,"h_index":24,"i10_index":48,"pubmed_count":11,"latest_activity_year":2026,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT02687763","title":"Safety and Efficacy of ProQuad® in Children 6-24 Month Being Evaluated for Solid Organ Transplant","phase":"EARLY_PHASE1","status":"COMPLETED","role":"Investigator","sponsor":"Medical University of South Carolina","source_url":"https://clinicaltrials.gov/study/NCT02687763","trial_url":"https://www.findmykol.com/trial/NCT02687763"}],"source":"trials"},"payments":{"company_count":6,"program_years":{"first":2021,"last":2025},"rows_total":13,"shown":3,"withheld":10,"rows":[{"payer":"Travere Therapeutics, Inc.","program_year":2025,"amount_usd":6194.52,"payment_count":8,"source_url":"https://openpaymentsdata.cms.gov/search?query=1356532311"},{"payer":"ARGENX US, INC.","program_year":2025,"amount_usd":600,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1356532311"},{"payer":"Alexion Pharmaceuticals, Inc.","program_year":2025,"amount_usd":122.4,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1356532311"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1356532311","source":"payments"},"prescribing":{"data_year":2024,"areas_total":5,"areas_shown":3,"areas":[{"area":"Metabolism & gastrointestinal","share_pct":36.9,"classes_total":4,"classes":[{"class":"H2 blocker","setting":"prescribed","share_pct":12,"drugs":[{"name":"Famotidine","share_pct":100}],"max_beneficiaries":null},{"class":"Corticosteroid","setting":"prescribed","share_pct":10.7,"drugs":[{"name":"Prednisone","share_pct":100}],"max_beneficiaries":null}]},{"area":"Cardiovascular","share_pct":23.6,"classes_total":2,"classes":[{"class":"Calcium channel blocker","setting":"prescribed","share_pct":16.3,"drugs":[{"name":"Amlodipine Besylate","share_pct":71.1},{"name":"Katerzia","share_pct":28.9}],"max_beneficiaries":null},{"class":"ACE inhibitor","setting":"prescribed","share_pct":7.3,"drugs":[{"name":"Lisinopril","share_pct":100}],"max_beneficiaries":null}]},{"area":"Anti-infectives","share_pct":15.9,"classes_total":2,"classes":[{"class":"Azole Antifungal","setting":"prescribed","share_pct":9.9,"drugs":[{"name":"Fluconazole","share_pct":100}],"max_beneficiaries":null},{"class":"Short-acting sulfonamides","setting":"prescribed","share_pct":6,"drugs":[{"name":"Sulfamethoxazole-Trimethoprim","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2021,"office_pct":100,"facility_pct":0},"source":"medicare"},"funding":{"award_count":0,"rows_total":0,"shown":0,"withheld":0,"rows":[],"source":"grants"},"publications":{"total":11,"shown":5,"withheld":6,"matched_by":"ORCID record, linked to PubMed","recent":[{"title":"Perspectives and Practices in Pediatric to Adult Healthcare Transition in Kidney Transplantation: An American Society of Transplantation (AST) Member Survey.","year":2026,"journal":"Pediatric transplantation","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/41830051/","status":"verified"},{"title":"Pediatric to Adult Transition in Solid Organ Transplant Recipients: A Systematic Review of Existing Transition Programs.","year":2024,"journal":"Pediatric transplantation","types":["Systematic Review","Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/39559923/","status":"verified"},{"title":"Antibody-mediated rejection in pediatric kidney transplant recipients: A report from the Pediatric Nephrology Research Consortium.","year":2024,"journal":"Pediatric transplantation","types":["Review","Journal Article","Research Support, N.I.H., Extramural"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/38602171/","status":"verified"},{"title":"Highlights from the 12th congress of the international pediatric transplant association, Austin, Texas 2023.","year":2023,"journal":"Pediatric transplantation","types":["Conference Proceedings"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/37632202/","status":"verified"},{"title":"Indomethacin patent ductus arteriosus prophylaxis in the modern era: renal implications.","year":2023,"journal":"Journal of perinatology : official journal of the California Perinatal Association","types":["Journal Article","Research Support, Non-U.S. Gov't"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/37085522/","status":"verified"}],"most_cited":{"total":118,"shown":5,"withheld":113,"rows":[{"title":"FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1","year":2009,"cited_by_count":438,"type":"article","source_url":"https://doi.org/10.1152/ajprenal.90742.2008"},{"title":"CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease","year":2018,"cited_by_count":140,"type":"article","source_url":"https://doi.org/10.1053/j.ajkd.2018.07.020"},{"title":"Establishing core outcome domains in pediatric kidney disease: report of the Standardized Outcomes in Nephrology—Children and Adolescents (SONG-KIDS) consensus workshops","year":2020,"cited_by_count":102,"type":"article","source_url":"https://doi.org/10.1016/j.kint.2020.05.054"},{"title":"Regulation of serum 1,25(OH) 2 Vitamin D 3 levels by fibroblast growth factor 23 is mediated by FGF receptors 3 and 4","year":2011,"cited_by_count":101,"type":"article","source_url":"https://doi.org/10.1152/ajprenal.00740.2010"},{"title":"Clinical Characteristics and Treatment Patterns of Children and Adults With IgA Nephropathy or IgA Vasculitis: Findings From the CureGN Study","year":2018,"cited_by_count":85,"type":"article","source_url":"https://doi.org/10.1016/j.ekir.2018.07.021"}]},"source":"publications"},"network":{"coauthors_total":40,"shown":3,"withheld":37,"coauthors":[{"name":"Scott E. Wenderfer","coauthored_works":21,"profile_url":"https://www.findmykol.com/kol/scott-wenderfer"},{"name":"William E. Smoyer","coauthored_works":19},{"name":"David T. Selewski","coauthored_works":19}],"source":"works"},"presence":{"owned_accounts":{"total":4,"shown":3,"rows":[{"platform":"other","url":"https://www.lens.org/lens/orcid/0000-0003-2073-2834","status":"verified"},{"platform":"doximity","url":"https://www.doximity.com/pub/katherine-twombley-md","status":"provisional"},{"platform":"linkedin","url":"https://www.linkedin.com/in/twombley-katherine-b9553178","status":"provisional"}]},"mentions":{"total":2,"shown":2,"rows":[{"url":"https://ce.nemours.org/node/25195/bio/48455/view","platform":"other","status":"verified"},{"url":"https://nemours.mediaroom.com/news-releases?item=123201","platform":"other","status":"provisional"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"recognition":{"education":{"total":5,"shown":5,"rows":[{"value":"Fellowship in Pediatric Nephrology, University of Texas Southwestern Medical Center/Dallas Children's Hospital, 2010","source_url":"https://education.musc.edu/muscapps/facultydirectory/Twombley-Katherine","status":"verified","collected_at":"2026-10-30"},{"value":"Residency in Pediatrics, Miami Children’s Hospital, 2007","source_url":"https://education.musc.edu/muscapps/facultydirectory/Twombley-Katherine","status":"verified","collected_at":"2026-10-30"},{"value":"M.D., Medical University of South Carolina, 2004","source_url":"https://education.musc.edu/muscapps/facultydirectory/Twombley-Katherine","status":"verified","collected_at":"2026-10-30"},{"value":"B.A. in Biology, College of Charleston, 1996","source_url":"https://education.musc.edu/muscapps/facultydirectory/Twombley-Katherine","status":"verified","collected_at":"2026-10-30"},{"value":"Board-certified in Pediatrics and Pediatric Nephrology, American Board of Pediatrics","source_url":"https://ce.nemours.org/node/25195/bio/48455/view","status":"verified","collected_at":"2026-10-30"}]},"roles":{"total":1,"shown":1,"rows":[{"value":"Chair, Pediatric Community of Practice, American Society of Transplantation","source_url":"https://education.musc.edu/muscapps/facultydirectory/Twombley-Katherine","status":"provisional","collected_at":"2026-10-30"}]},"awards":{"total":1,"shown":1,"rows":[{"value":"Fellow designations: FAAP, FAST","source_url":"https://ce.nemours.org/node/25195/bio/48455/view","status":"verified","collected_at":"2026-10-30"}]},"secondary_affiliations":{"total":2,"shown":2,"rows":[{"value":"Medical University of South Carolina (Adjunct Professor)","source_url":"https://orcid.org/0000-0003-2073-2834","status":"verified","collected_at":"2026-10-30"},{"value":"Nemours Children's Clinic (Chair, Department of Pediatrics)","source_url":"https://orcid.org/0000-0003-2073-2834","status":"verified","collected_at":"2026-10-30"}]},"media":{"total":6,"shown":3,"rows":[{"value":"Interview recap, Saying Yes and Putting Patients First (YouTube)","source_url":"https://www.youtube.com/watch?v=VeBx9rzGzJU","status":"provisional","collected_at":"2026-10-30"},{"value":"Speaking Of Show podcast interview, Removing Barriers & Welcoming Innovation","source_url":"https://podcasts.apple.com/us/podcast/removing-barriers-welcoming-innovation-interview-with/id1549592446?i=1000580117350&uo=4","status":"provisional","collected_at":"2026-10-30"},{"value":"The Kidney Chronicles Podcast, FSGS recurrence episode","source_url":"https://kidney.wiki/kidney-chronicles-podcast/","status":"provisional","collected_at":"2026-10-30"}]},"public_positions":{"total":1,"shown":1,"rows":[{"value":"Advocates for preventing physician burnout and suicide (personal site)","source_url":"https://www.katherinetwombley.com/","status":"provisional","collected_at":"2026-10-30"}]}},"similar":[{"name":"James Meschia","slug":"james-meschia","institution":"Mayo Clinic Florida","specialty":"Neurology","url":"https://www.findmykol.com/kol/james-meschia","json_url":"https://www.findmykol.com/kol/james-meschia/profile.json"},{"name":"Vivek Kumbhari","slug":"vivek-kumbhari","institution":"Mayo Clinic Florida","specialty":"Gastroenterology","url":"https://www.findmykol.com/kol/vivek-kumbhari","json_url":"https://www.findmykol.com/kol/vivek-kumbhari/profile.json"},{"name":"Ryan Uitti","slug":"ryan-uitti","institution":"Mayo Clinic Florida","specialty":"Neurology","url":"https://www.findmykol.com/kol/ryan-uitti","json_url":"https://www.findmykol.com/kol/ryan-uitti/profile.json"},{"name":"Howard Scher","slug":"howard-scher","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/howard-scher","json_url":"https://www.findmykol.com/kol/howard-scher/profile.json"},{"name":"Toni Choueiri","slug":"toni-choueiri","institution":"Dana-Farber Cancer Institute","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/toni-choueiri","json_url":"https://www.findmykol.com/kol/toni-choueiri/profile.json"},{"name":"Robert Motzer","slug":"robert-motzer","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/robert-motzer","json_url":"https://www.findmykol.com/kol/robert-motzer/profile.json"},{"name":"Fred Saad","slug":"fred-saad","institution":"Centre hospitalier de l'Université de Montréal (CHUM)","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/fred-saad","json_url":"https://www.findmykol.com/kol/fred-saad/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":10,"publications":6,"network":37}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-10-30"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-10-30"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 to 2025","collected_at":"2026-10-30"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"},"publications":{"name":"PubMed (NLM)","url":"https://pubmed.ncbi.nlm.nih.gov","provides":"Peer-reviewed publications, linked to the PubMed record","collected_at":"2026-10-30"}},"methodology_url":"https://www.findmykol.com/about#methodology"}